Sol-Gel Technologies Ltd.

Rentabilité sur six mois: +1 093.27%
Rendement en dividendes: 0%
Secteur: Healthcare

7.52 $

0 $ 0%
0.366 $
7.85 $

paper.min_max_per_year

Calendrier des promotions Sol-Gel Technologies Ltd.

À propos de l'entreprise Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; SGT-610, a rare disease for the treatment of Gorlin Syndrome which has completed Phase II clinical trials; and Erlotinib and Tapinarof to treat other rare skin indications. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

Paramètres de base

IPO date
2018-01-23
ISIN
IL0011417206
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 2.7 6
P/BV 1.08 9
P/E 0 0
Efficacité
Nom Signification Grade
ROA -26.08 0
ROE -31.35 0
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA -0.1264 10
Debt/Ratio 0.0365 10
Debt/Equity 0.2425 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 31.11 5
Rentabilité Ebitda, % -65.74 0
Rentabilité EPS, % -68.71 0

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 7.52 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 6.92 $ 0 $ 0 $ 8.67 % 0 % 0 %
common.calendar.number_days.30d 7.59 $ 6.9 $ 7.52 $ -0.92 % 0 % 0 %
common.calendar.number_days.90d 0.43 $ 0.41 $ 7.85 $ 1648.84 % 0 % 0 %
common.calendar.number_days.180d 0.6302 $ 0.41 $ 7.85 $ 1093.27 % 0 % 0 %
common.calendar.number_days.1y 0.6584 $ 0.366 $ 7.85 $ 1042.16 % 0 % 0 %
common.calendar.number_days.3y 6.05 $ 0.366 $ 7.85 $ 24.3 % 0 % 0 %
common.calendar.number_days.5y 7.9 $ 0.366 $ 15.49 $ -4.81 % 0 % 0 %
common.calendar.number_days.10y 0.366 $ 0.366 $ 17.15 $ 2054.64 % 0 % 0 %
common.calendar.number_days.ytd 0.732 $ 0.41 $ 7.85 $ 927.32 % 0 % 0 %

Principaux propriétaires

Entreprises similaires



Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Dr. Alon Seri-Levy Co-Founder, CEO & Director 411k 1961 (64 année)
Mr. Gilad Mamlok Advisor 367k 1968 (57 années)
Dr. Itzik Yosef Chief Operating Officer 236k 1976 (49 années)
Mr. Moshe Arkin Executive Chairman of the Board N/A 1953 (72 année)
Prof. David Avnir Co-Founder N/A
Ms. Tamar Fishman Jutkowitz VP & General Counsel N/A 1976 (49 années)
Dr. Karine Neimann VP of Projects & Planning and Chief Chemist N/A 1971 (54 année)
Mr. Eyal Ben-Or Chief Financial Officer

Informations sur l'entreprise

Adresse: Israel, Ness Ziona, 7 Golda Meir Street - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.sol-gel.com